<text id="autogum_bio_doc34" title="Romina Mizrahi" shortTile="romina-mizrahi" type="bio" dateCollected="2019-11-05" dateCreated="2019-01-04" dateModified="2019-04-23" sourceURL="https://en.wikipedia.org/wiki/Romina_Mizrahi" speakerList="none" speakerCount="0">
<head>Romina Mizrahi</head>
<p><hi rend="bold">Romina Mizrahi</hi> is an Argentine-Canadian Associate Professor of <ref target="https://en.wikipedia.org/wiki/Psychiatry">Psychiatry</ref> at the <ref target="https://en.wikipedia.org/wiki/University_of_Toronto">University of Toronto</ref> and is a Head of the Focus on Youth Psychosis Prevention Clinic of the <ref target="https://en.wikipedia.org/wiki/Centre_for_Addiction_and_Mental_Health">Centre for Addiction and Mental Health</ref>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-1">[1]</ref></p>
<head>Early and personal life</head>
<p>Romina Mizrahi had obtained her M.D. degree from the <ref target="https://en.wikipedia.org/wiki/University_of_Buenos_Aires">University of Buenos Aires</ref> in 1998 and in 2007 got her Ph.D. from the <ref target="https://en.wikipedia.org/wiki/University_of_Toronto">University of Toronto</ref>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-2">[2]</ref> In 2008 she and her husband had moved to Canada and had two little girls which are three and nine months respectively.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-3">[3]</ref></p>
<head>Career</head>
<p>Dr. Mizrahi is specializing in <ref target="https://en.wikipedia.org/wiki/Magnetic_resonance_imaging">MRI</ref>, <ref target="https://en.wikipedia.org/wiki/Positron_emission_tomography">PET</ref>, <ref target="https://en.wikipedia.org/wiki/Phenomenology_(psychology)">phenomenology</ref> and <ref target="https://en.wikipedia.org/wiki/Pathophysiology">pathophysiology</ref> and is an active seeker for the cure of <ref target="https://en.wikipedia.org/wiki/Schizophrenia">schizophrenia</ref>. She had received numerous funds from the <ref target="https://en.wikipedia.org/wiki/National_Institute_of_Mental_Health">National Institute of Mental Health</ref>, <ref target="https://en.wikipedia.org/wiki/Canadian_Institutes_of_Health_Research">Canadian Institutes of Health Research</ref> and Ontario Mental Health Foundation with which she was able to develop a new <ref target="https://en.wikipedia.org/wiki/Radioligand">radioligand</ref> F-18. This advancement shed the light for her to continue research with the <ref target="https://en.wikipedia.org/wiki/Alzheimer_Society_of_Canada">Alzheimer Society of Canada</ref> and the <ref target="https://en.wikipedia.org/wiki/Brain_&amp;_Behavior_Research_Foundation">Brain &amp; Behavior Research Foundation</ref> to test it on humans.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-4">[4]</ref><ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-5">[5]</ref></p>
<head>2015</head>
<p>From 2015 to 2018 Romina Mizrahi had worked along with <ref target="https://en.wikipedia.org/wiki/Tomas_Paus">Tomas Paus</ref> and studied more than 1,600 boys from Canada, Britain, France, Germany and Ireland. The study looked into brain scans, cannabis history and genetic schizophrenia of the patients and was proven that there is cause-and-effect relationship between cannabis and brain changes.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-6">[6]</ref></p>
<p>In 2015 she led a research along with Sinthu Suntharalingam at the <ref target="https://en.wikipedia.org/wiki/Children's_Hospital_of_Eastern_Ontario">Children's Hospital of Eastern Ontario</ref> on teenagers who used <ref target="https://en.wikipedia.org/wiki/Marijuana_(word)">marijuana</ref> and proved that because it uses <ref target="https://en.wikipedia.org/wiki/Endocannabinoid_system">endocannabinoid system</ref>,<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-7">[7]</ref> it shouldn't be used for people under the age of 25<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-8">[8]</ref> due to risk of <ref target="https://en.wikipedia.org/wiki/Memory_loss">memory loss</ref>, eruption of symptoms of schizophrenia and <ref target="https://en.wikipedia.org/wiki/Psychosis">psychosis</ref><ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-9">[9]</ref> and even permanent <ref target="https://en.wikipedia.org/wiki/Brain_damage">brain damage</ref>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-10">[10]</ref></p>
<head>2016</head>
<p>In June 2016 she and Cory Gerritsen had studied cannabis' ingredients; <ref target="https://en.wikipedia.org/wiki/Cannabidiol">cannabidiol</ref> and <ref target="https://en.wikipedia.org/wiki/Tetrahydrocannabinol">tetrahydrocannabinol</ref> and proved that the latter causes <ref target="https://en.wikipedia.org/wiki/Psychosis">psychosis</ref> in adolescents.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-11">[11]</ref> On November of the same year Dr. Mizrahi worked with Dr. Bill MacEwan on a case of a 21-year old  who killed a 13-year old tween while being influenced by cannabis.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-12">[12]</ref></p>
<head>2017</head>
<p>In January 2017 Mizrahi had studied Canadian immigrants for the symptoms of schizophrenia which was caused by <ref target="https://en.wikipedia.org/wiki/Dopamine">dopamine</ref><ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-13">[13]</ref> and established a possible link between migration and psychosis.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-14">[14]</ref> In May of the same year she had partnered with Diane Kelsall who was a chief editor of the <hi rend="italic"><ref target="https://en.wikipedia.org/wiki/Canadian_Medical_Association_Journal">Canadian Medical Association Journal</ref></hi> to push for a stricter guidelines in the <hi rend="italic"><ref target="https://en.wikipedia.org/wiki/Cannabis_Act">Cannabis Act</ref></hi>, which were approved later on by the <ref target="https://en.wikipedia.org/wiki/Minister_of_Health_(Canada)">Canadian Minister of Health</ref> <ref target="https://en.wikipedia.org/wiki/Jane_Philpott">Jane Philpott</ref>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-15">[15]</ref></p>
<head>2018</head><p>
In May 2018, in an interview with <hi rend="italic"><ref target="https://en.wikipedia.org/wiki/Leafly">Leafly</ref></hi>, she told the site that </p><p>Cannabis could be a trigger of an underlying condition.</p><p> and that </p><p>There is a proven link between cannabis and psychotic experience, [but] who will experience those symptoms or when [remains unclear].</p><p><ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-16">[16]</ref></p>
<p>In July 2018 Romina Mizrahi had suggested that <ref target="https://en.wikipedia.org/wiki/Cortisol">cortisol</ref>, the main stress hormone, is responsible for stress regulatory system failures with schizophrenic patients by studying their <ref target="https://en.wikipedia.org/wiki/Striatum">striatum</ref>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-17">[17]</ref></p>
<p>In October 2018 Dr. Mizrahi partnered with Randi Schuster of <ref target="https://en.wikipedia.org/wiki/Massachusetts_General_Hospital">Massachusetts General Hospital</ref> and published their work on cannabis in <hi rend="italic"><ref target="https://en.wikipedia.org/wiki/The_Journal_of_Clinical_Psychiatry">The Journal of Clinical Psychiatry</ref></hi>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-18">[18]</ref></p>
<head>Works</head>
<list type="unordered"><item>2018 - <hi rend="italic">Molecular imaging studies in youth with psychosis and psychosis risk with Dr Romina Mizrahi</hi><ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-19">[19]</ref></item></list>
</text>
